| Literature DB >> 33228659 |
Timothy Awine1,2, Sheetal P Silal3,4.
Abstract
BACKGROUND: This paper investigates the impact of malaria preventive interventions in Ghana and the prospects of achieving programme goals using mathematical models based on regionally diverse climatic zones of the country. <br> METHODS: Using data from the District Health Information Management System of the Ghana Health Service from 2008 to 2017, and historical intervention coverage levels, ordinary non-linear differential equations models were developed. These models incorporated transitions amongst various disease compartments for the three main ecological zones in Ghana. The Approximate Bayesian Computational sampling approach, with a distance based rejection criteria, was adopted for calibration. A leave-one-out approach was used to validate model parameters and the most sensitive parameters were evaluated using a multivariate regression analysis. The impact of insecticide-treated bed nets and their usage, and indoor residual spraying, as well as their protective efficacy on the incidence of malaria, was simulated at various levels of coverage and protective effectiveness in each ecological zone to investigate the prospects of achieving goals of the Ghana malaria control strategy for 2014-2020. <br> RESULTS: Increasing the coverage levels of both long-lasting insecticide-treated bed nets and indoor residual spraying activities, without a corresponding increase in their recommended utilization, does not impact highly on averting predicted incidence of malaria. Improving proper usage of long-lasting insecticide-treated bed nets could lead to substantial reductions in the predicted incidence of malaria. Similar results were obtained with indoor residual spraying across all ecological zones of Ghana. <br> CONCLUSIONS: Projected goals set in the national strategic plan for malaria control 2014-2020, as well as World Health Organization targets for malaria pre-elimination by 2030, are only likely to be achieved if a substantial improvement in treated bed net usage is achieved, coupled with targeted deployment of indoor residual spraying with high community acceptability and efficacy.Entities:
Keywords: Indoor residual spraying; Interventions; Long lasting insecticide bednets; Malaria; Model
Mesh:
Substances:
Year: 2020 PMID: 33228659 PMCID: PMC7684904 DOI: 10.1186/s12936-020-03496-y
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Malaria transmission model showing various compartments of both human and vector populations
Parameter values
| Parameter name | Parameter value by Zone | Parameter definition | Source | ||||
|---|---|---|---|---|---|---|---|
| Guinea Savannah | Transitional Forest | Coastal Savannah | |||||
| pc1 | 0.90 | 0.90 | 0.80 | Probability of naive progressing into | Estimated | ||
| pa1 | 0.35 | 0.07 | 0.58 | Probability of naive progressing into | Estimated | ||
| pc2 | 0.14 | 0.19 | 0.14 | Probability of non-naive progressing into | Estimated | ||
| pa2 | 0.61 | 0.39 | 0.49 | Probability of non-naive progressing into | Estimated | ||
| Ps | 0.130 | 0.065 | 0.062 | Probability of progressing into severe disease | [ | ||
| pt1 | 0.87 | 0.88 | 0.88 | Probability of being tested/diagnosed for uncomplicated malaria | [ | ||
| Ppc | 0.81 | 0.70 | 0.80 | Proportion of pregnant women from | Estimated | ||
| Ppa | 0.250 | 0.075 | 0.540 | Proportion of pregnant women from | Estimated | ||
| X | 0.01 | 0.01 | 0.01 | Probability of progressing from | Estimated | ||
| m1 | 0.57 | 0.10 | 0.10 | Probability of infection among children under 6 years and pregnant women | Estimated | ||
| m2 | 0.77 | 0.22 | 0.20 | Probability of infection among non-naive population 6 years and above | Estimated | ||
| Pst | 0.80 | 0.71 | 0.73 | Probability of seeking treatment at the health facility | [ | ||
| Prob_inf | 0.50 | Probability of a bite resulting into a mosquito being infected or a human being infected following a bite from an mosquito | [ | ||||
| Pn | 0.125 | 0.125 | 0.125 | Proportion of population of children under 6 years | [ | ||
| Pm | 0.874375 | 0.87425 | 0.8744125 | Proportion of population 6 years and above | [ | ||
| pt2 | 0.99 | 0.99 | 0.99 | Probability of being treated with | [ | ||
| ah1 | 0.385 | 0.385 | 0.385 | Proportion non-adherent to | [ | ||
| ah2 | 0.092 | 0.082 | 0.082 | Proportion non-adherent to | [ | ||
| Px | 0.025 | Proportion of pregnant women in the population | [ | ||||
| rs1 | 0.04 | 0.04 | 0.04 | Resistance against | [ | ||
| rs2 | 0.01 | 0.01 | 0.01 | Resistance against | [ | ||
| rs3 | 0.0962 | 0.0962 | 0.0962 | Resistance against | [ | ||
| ac1 | 0.134 | 0.126 | 0.112 | Probability of asymptomatic malaria among pregnant women at | [ | ||
| ac2 | 0.097 | 0.097 | 0.097 | Probability of sub-microscopic infection among pregnant women at | [ | ||
| pt3 | 0.367 | Proportion of pregnant women taking up at least 3 dose | [ | ||||
| ah3 | 0.633 | Proportion of pregnant women not taking up at least 3 doses | [ | ||||
| Nn | 5.1 × 106 | 17.1 × 106 | 8.1 × 106 | Human population size (2018 mid-year estimated) (number) | DHIMS2 | ||
| Ln | 25 | 30.6 | 23.5 | birth/death rate per 1000 population (year−1) | [ | ||
| Kv | 7.8 × 105 | 4.2 × 107 | 2.5 × 107 | Carrying capacity of the environment for larva and pupae stages of mosquitoes (ha−1) | estimated | ||
| LLIN | 0.398 | Protective efficacy of | [ | ||||
| IRS | 0.285 | Protective efficacy of | [ | ||||
| Ss | 365.25/5 | Rate of progressing into severe disease (day−1) | [ | ||||
| Q | 365.25/194 | Duration of progressing from | [ | ||||
| gamma | 365.25/21 | Duration of latent period in human population (day−1) | [ | ||||
| t1 | 365.25/3 | Duration after onset of illness | [ | ||||
| rho1 | 365.25/3 | Recovery rate after ACT treatment (day−1) | [ | ||||
| rho2 | 365.25/6 | Recovery rate after | [ | ||||
| V | 52/5.5 | Rate of recovery from | [ | ||||
| Nr | 365.25/130 | Rate of natural recovery from infection (day−1) | [ | ||||
| AC | 365.25/30 | Rate of antenatal attendance (day−1) | [ | ||||
| Hlsp | 365.25/8 | Rate of recovering after | [ | ||||
| RDTMicSens | 0.49 | Average sensitivity of | [ | ||||
| Reporting | 0.969 | 0.966 | 0.947 | Reporting probability of uncomplicated malaria at health facility (proportion) | Data from NMCP | ||
aIRR incidence rate ratio
bOR Odds ratio
Fig. 2Monthly biting rates (b/p/m) [Grey Bars] and rainfall (mm) [Blue Lines] in the Guinea savannah, Transitional forest and Coastal savannah, respectively
Fig. 3Probability of testing all suspected malaria cases by zone (Source: NMCP).
Fig. 5Impact of attaining various levels of LLINs coverage within a 3-year implementation programme at a usage level of 60.0% while maintaining IRS coverage and PE at prevailing baseline levels in the a Guinea savannah, b transitional forest and c coastal savannah
Fig. 6Impact of attaining various levels of IRS coverage within a 5-year implementation programme at various protective efficacy (PE) while maintaining IRS coverage at 90.0% and PE, coverage levels and usage of LLINs at prevailing baseline levels in the a Guinea savannah, b transitional forest and c coastal savannah
Fig. 7Impact of attaining a combination of various levels of LLINs and IRS coverage within 3 and 5 year implementation programme respectively at baseline protective Efficacy (PE) of IRS (30.0%) and elevated level of LLINs (60.0%) usage in the a Guinea savannah, b transitional forest and c coastal savannah
Fig. 4Model run time is 1988 to 2030. Steady state period spans from 1988 to 1997, 1998 to 2017 previous interventions implemented and reporting rates on DHIMS introduced. Data fitting and calibration from 2008 to 2017 for the a Guinea savannah, b transitional forest and c coastal savannah
Predictions of reported clinical malaria (uncomplicated and severe cases) incidence rate per 1000 population with 95% pseudo-confidence intervals (95% p.CI) for various coverage levels of LLINs and IRS and LLIN usage (%) or IRS protective efficacy (PE) (%) at 2020 and by 2030 by zone
| Zone | Intervention | Coverage (%) | Usage (%) | PE (%) | Incidence rate/1000 population | |||
|---|---|---|---|---|---|---|---|---|
| (95% p.CI) by yeara | ||||||||
| LLIN | IRSb | LLIN | LLIN | IRS | 2020 | 2030 | ||
| Guinea savannah | LLINs | 70 | 17 | 56 | 40 | 30 | 169 (117, 245) | 168 (116, 245) |
| 60 | 40 | 30 | 166 (114, 242) | 165 (112,241) | ||||
| 80 | 40 | 30 | 150 (97, 223) | 148 (91,222) | ||||
| 90 | 17 | 56 | 40 | 30 | 160 (108, 245) | 155 (100, 230) | ||
| 60 | 40 | 30 | 156 (104, 230) | 151 (94, 225) | ||||
| 80 | 40 | 30 | 136 (84, 206) | 125 (62, 196) | ||||
| Transitional forest | LLINs | 70 | 0 | 45 | 40 | 30 | 189 (157, 226) | 177 (139, 215) |
| 60 | 40 | 30 | 171 (139,206) | 148 (103, 186) | ||||
| 80 | 40 | 30 | 146 (115,179) | 107(57,145) | ||||
| 90 | 0 | 45 | 40 | 30 | 179 (148, 226) | 159 (109, 190) | ||
| 60 | 40 | 30 | 158 (126, 191) | 113 (64, 151) | ||||
| 80 | 40 | 30 | 130 (100, 160) | 60 (22, 93) | ||||
| Coastal savannah | LLINs | 70 | 0 | 35 | 40 | 30 | 97 (79, 110) | 87 (63, 104) |
| 60 | 40 | 30 | 77 (60, 91) | 51 (26,78) | ||||
| 80 | 40 | 30 | 62 (47, 77) | 27 (10,55) | ||||
| 90 | 0 | 35 | 40 | 30 | 92 (74, 110) | 73 (47, 94) | ||
| 60 | 40 | 30 | 69 (53, 83) | 31 (12, 58) | ||||
| 80 | 40 | 30 | 53 (39, 67) | 11 (4, 28) | ||||
a95% p.CI 2.5 and 97.5% quantiles around the mean of the distribution of the predicted clinical cases of malaria
bBaseline IRS coverage
Predictions of reported clinical malaria (uncomplicated and severe cases) incidence rate per 1000 population with 95% pseudo-confidence intervals (95% p.CI) for various coverage levels of LLINs and IRS and LLIN usage (%) or IRS protective efficacy (PE) (%) in 2020 and by 2030 by zone
| Zone | Intervention | Coverage (%) | Usage (%) | PE (%) | Incidence rate/1000 population | |||
|---|---|---|---|---|---|---|---|---|
| (95% p.CI) by yeara | ||||||||
| LLIN | IRS | LLIN | LLIN | IRS | 2020 | 2030 | ||
| Guinea savannah | IRS | 66 | 90 | 56 | 40 | 30 | 146 (95, 218) | 102 (36, 169) |
| 56 | 40 | 60 | 105 (59, 164) | 6 (1, 15) | ||||
| 56 | 40 | 80 | 78 (39, 125) | 0 (0, 1) | ||||
| Transitional forest | IRS | 51 | 90 | 45 | 40 | 30 | 159 (128, 192) | 35 (12,59) |
| 45 | 40 | 60 | 121 (94, 149) | 1 (1,1) | ||||
| 45 | 40 | 80 | 99 (75, 122) | 0 (0, 0) | ||||
| Coastal savannah | IRS | 50 | 90 | 35 | 40 | 30 | 75 (59, 89) | 8 (3, 20) |
| 35 | 40 | 60 | 53 (40, 65) | 0 (0, 0) | ||||
| 35 | 40 | 80 | 40 (30, 51) | 0 (0, 0) | ||||
a95% p.CI 2.5 and 97.5% quantiles around the mean of the distribution of the predicted clinical cases of malaria
Predictions of reported clinical malaria (uncomplicated and severe cases) incidence rate per 1000 population with 95% pseudo-confidence intervals (95% p.CI) for various coverage levels of LLINs and IRS and LLIN usage (%) or IRS protective efficacy (PE) (%) in 2020 and by 2030 by zone
| Zone | Intervention | Coverage (%) | Usage (%) | PE (%) | Incidence rate/1000 population | |||
|---|---|---|---|---|---|---|---|---|
| (95% p.CI) by yeara | ||||||||
| LLIN | IRS | LLIN | LLIN | IRS | 2020 | 2030 | ||
| Guinea savannah | LLIN and IRS | 80 | 80 | 56 | 40 | 30 | 144 (93, 214) | 103 (37, 170) |
| 90 | 90 | 56 | 40 | 30 | 136 (86, 204) | 83 (20, 146) | ||
| 80 | 80 | 60 | 40 | 30 | 140 (89, 210) | 98 (33, 165) | ||
| 80 | 90 | 60 | 40 | 30 | 137 (86, 206) | 86 (23,151) | ||
| Transitional forest | LLIN and IRS | 80 | 80 | 45 | 40 | 30 | 150 (120, 183) | 29 (9, 51) |
| 90 | 90 | 45 | 40 | 30 | 142 (113, 173) | 16 (5,29) | ||
| 80 | 80 | 60 | 40 | 30 | 133 (103, 163) | 16 (5, 30) | ||
| 80 | 90 | 60 | 40 | 30 | 129 (100, 159) | 10 (4, 20) | ||
| Coastal savannah | LLIN and IRS | 80 | 80 | 35 | 40 | 30 | 72 (56, 85) | 7 (3, 18) |
| 90 | 90 | 35 | 40 | 30 | 67 (52, 80) | 4 (2, 10) | ||
| 80 | 80 | 60 | 40 | 30 | 55 (41, 68) | 2 (1,6) | ||
| 80 | 90 | 60 | 40 | 30 | 53 (39, 66) | 2 (1, 4) | ||
a95% p.CI 2.5 and 97.5% quantiles around the mean of the distribution of the predicted clinical cases of malaria